Abstract:Numerous studies revealed that spinal inflammation and immune response play an important role in neuropathic pain. In this study, we investigated the effects of intrathecal injection of a Toll-like receptor (TLR4) inhibitor epigallocatechin gallate (EGCG) on neuropathic pain induced by chronic constriction injury of the sciatic nerve (CCI). A total of 120 rats were randomly assigned into 4 groups: sham-operated group, CCI group, CCI plus normal saline group and CCI plus EGCG group. CCI and sham surgeries were performed and both thermal hyperalgesia and mechanical allodynia were tested. Lumbar spinal cord was sampled and the mRNA and protein expressions of TLR4 and High Mobility Group 1 protein (HMGB1) were detected, the contents of tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-10 (IL-10) were measured by ELISA, and immunohistochemistry for nuclear factor kappa B (NF-κB) was also carried out. When compared with the sham group, both mechanical and heat pain thresholds were significantly decreased, and the mRNA and protein expressions of TLR4 and HMGB1, the contents of TNF-α, IL-1β and IL-10 in the spinal cords and NF-κB expression in the spinal dorsal horn were markedly increased in CCI rats (P<0.05). After intrathecal injection of EGCG (1mg/kg) once daily from 1day before to 3days after CCI surgery, the expressions of TLR4, NF-κB, HMGB1, TNF-α and IL-1β were markedly decreased while the content of IL-10 in the spinal cord increased significantly accompanied by dramatical improvement of pain behaviors in CCI rats (P<0.05). These results show that the TLR4 signaling pathway plays an important role in the occurrence and development of neuropathic pain, and the therapy targeting TLR4 might be a novel strategy in the treatment of neuropathic pain.

The effect of Toll-like receptor 4 in the mechanisms of neuropathic pain development

Toll-like receptor 4: the potential therapeutic target for neuropathic pain]

Effect of the Melanocortin Receptor-4 in Neuropathic Pain

The Role of P2X4 Receptor in Neuropathic Pain and Its Pharmacological Properties

Changes of Toll-like receptor 4 and its downstream cytokines in spinal cord of rat model of neuropathic pain

Targeting toll-like receptor-4 (TLR4)—an emerging therapeutic target for persistent pain states

Toll-like Receptors and Their Role in Neuropathic Pain and Migraine

Effects of Intrathecal Epigallocatechin Gallate, an Inhibitor of Toll-like Receptor 4, on Chronic Neuropathic Pain in Rats

A TRPV4-dependent Neuroimmune Axis in the Spinal Cord Promotes Neuropathic Pain

Lentiviral‑mediated Inducible Silencing of TLR4 Attenuates Neuropathic Pain in a Rat Model of Chronic Constriction Injury.

TLR-4: a promising target for chemotherapy-induced peripheral neuropathy

Immune mechanism in neuropathic pain

Intrathecal Sirna Against Toll-like Receptor 4 Reduces Nociception in a Rat Model of Neuropathic Pain

TLR4 deficiency abrogated widespread tactile allodynia, but not widespread thermal hyperalgesia and trigeminal neuropathic pain after partial infraorbital nerve transection.

Emerging Role of Toll-like Receptors in the Control of Pain and Itch

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Analgesic Effects of TLR4/NF-κB Signaling Pathway Inhibition on Chronic Neuropathic Pain in Rats Following Chronic Constriction Injury of the Sciatic Nerve.

A comprehensive review of traditional Chinese medicine in treating neuropathic pain

Toll-like receptor 4: A potential therapeutic target for multiple human diseases

Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy